Literature DB >> 1960397

CD4 rat x rat and mouse x rat T cell hybridomas produced by fusion of established T cell lines and clones to W/Fu (C58NT)D.

A M Boots1, M J van Lierop, M H Wauben, P J van Kooten, E J Hensen, W van Eden.   

Abstract

Previously, fusion of established T cell lines or clones has been claimed to be difficult. We now report our experiences in the fusion of both long term cultures of rat T cell clones and mouse T cell lines to rat W/Fu (C58NT)D. Upon fusion of rat T cell clones the hybrids obtained expressed antigen specificities identical to those of the parent clones. In addition, C58 was used for interspecies hybridisation of murine T cell lines. The specificity of intra- and inter-species hybrids was maintained by subcloning. We conclude that the C58 cell line can be used to generate continuously growing monoclonal T-cell reagents of sufficient stability using both intra- and inter-species hybridisation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1960397      PMCID: PMC7130835          DOI: 10.1016/0022-1759(91)90223-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  32 in total

1.  T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis.

Authors:  I R Cohen; J Holoshitz; W van Eden; A Frenkel
Journal:  Arthritis Rheum       Date:  1985-08

2.  Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity.

Authors:  A Conzelmann; P Corthésy; M Cianfriglia; A Silva; M Nabholz
Journal:  Nature       Date:  1982-07-08       Impact factor: 49.962

3.  Characterization of murine thymocytes with CD3-associated T-cell receptor structures.

Authors:  J A Bluestone; D Pardoll; S O Sharrow; B J Fowlkes
Journal:  Nature       Date:  1987 Mar 5-11       Impact factor: 49.962

4.  A simple technique to distinguish rat from mouse chromosomes in T cell hybridomas.

Authors:  D Simon; S Valentine; E Heber-Katz; B B Knowles
Journal:  Hybridoma       Date:  1988-06

5.  Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus.

Authors:  T Fukumoto; W R McMaster; A F Williams
Journal:  Eur J Immunol       Date:  1982-03       Impact factor: 5.532

6.  Unexpected expression of a unique mixed-isotype class II MHC molecule by transfected L-cells.

Authors:  R N Germain; H Quill
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

7.  Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins.

Authors:  K K Stanley; J P Luzio
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

8.  The peplomer protein sequence of the M41 strain of coronavirus IBV and its comparison with Beaudette strains.

Authors:  H G Niesters; J A Lenstra; W J Spaan; A J Zijderveld; N M Bleumink-Pluym; F Hong; G J van Scharrenburg; M C Horzinek; B A van der Zeijst
Journal:  Virus Res       Date:  1986-08       Impact factor: 3.303

9.  Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells.

Authors:  W M Kast; L P de Waal; C J Melief
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

10.  Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses.

Authors:  G Geering; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  3 in total

1.  Liposomes with incorporated MHC class II/peptide complexes as antigen presenting vesicles for specific T cell activation.

Authors:  A J van Rensen; M H Wauben; M C Grosfeld-Stulemeyer; W van Eden; D J Crommelin
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

2.  CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions.

Authors:  C P Broeren; M A Lucassen; M J van Stipdonk; R van der Zee; C J Boog; J G Kusters; W van Eden
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

3.  Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone.

Authors:  M H Wauben; C J Boog; R van der Zee; I Joosten; A Schlief; W van Eden
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.